WuXi PharmaTech (Cayman) Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Five

WuXi PharmaTech (Cayman) Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Five

WuXi PharmaTech (Cayman) Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $2.02 million as of 2014-12-31, per its 20-F filed 2015-04-15.

Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2015-04-15

• 2014-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $2.02M.
• 2013-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $545.00K.
• 2012-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $592.00K.